Segar, David J.
Bernstock, Joshua D.
Arnaout, Omar
Bi, Wenya Linda
Friedman, Gregory K.
Langer, Robert
Traverso, Giovanni
Rampersad, Sumientra M.
Article History
Received: 21 September 2022
Accepted: 24 January 2023
First Online: 30 January 2023
Change Date: 9 March 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-023-30970-9
Competing interests
: DJS is an officer and board member with equity in Saturn5 Corporation. JDB has an equity position in Treovir LLC and is a member of the POCKiT Diagnostics Board of Scientific Advisors. GKF is supported by Eli Lilly and Company and Pfizer through contracts to UAB. The remaining authors declare no pertinent conflicts of interest.